DWM
CVS icon

Doyle Wealth Management’s CVS Health CVS Stock Holding History

Doyle Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$311K Buy
3,262
+308
+10% +$30.5K 0.03% 158
2022
Q2 		$274K Buy
2,954
+17
+0.6% +$1.66K 0.02% 182
2022
Q1 		$297K Sell
2,937
-363
-11% -$38.1K 0.02% 199
2021
Q4 		$340K Buy
3,300
+2
+0.1% +$185 0.02% 179
2021
Q3 		$280K Buy
3,298
+60
+2% +$5.03K 0.02% 189
2021
Q2 		$270K Buy
3,238
+4
+0.1% +$328 0.02% 190
2021
Q1 		$243K Sell
3,234
-676
-17% -$49.2K 0.02% 192
2020
Q4 		$267K Buy
3,910
+224
+6% +$14.6K 0.03% 179
2020
Q3 		$215K Buy
3,686
+345
+10% +$21.5K 0.03% 174
2020
Q2 		$217K Sell
3,341
-1,136
-25% -$71.5K 0.03% 168
2020
Q1 		$266K Buy
4,477
+23
+0.5% +$1.53K 0.04% 146
2019
Q4 		$331K Buy
4,454
+197
+5% +$13.8K 0.04% 150
2019
Q3 		$269K Sell
4,257
-252
-6% -$14.9K 0.04% 168
2019
Q2 		$246K Buy
4,509
+16
+0.4% +$862 0.03% 171
2019
Q1 		$248K Buy
4,493
+541
+14% +$33.4K 0.04% 168
2018
Q4 		$259K Buy
3,952
+812
+26% +$60.6K 0.04% 156
2018
Q3 		$247K Sell
3,140
-9
-0.3% -$643 0.04% 171
2018
Q2 		$203K Buy
+3,149
New +$208K 0.03% 179
2018
Q1 		– Sell
-3,069
Closed -$222K – 171
2017
Q4 		$222K Sell
3,069
-143
-4% -$10.4K 0.04% 156
2017
Q3 		$261K Hold
3,212
– – 0.05% 128
2017
Q2 		$258K Buy
3,212
+558
+21% +$44.1K 0.05% 121
2017
Q1 		$208K Buy
+2,654
New +$212K 0.04% 127

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Doyle Wealth Management's CVS Position: Q3 2022 in Review

Doyle Wealth Management increased its CVS Health (CVS) stake by 10% in Q3 2022, buying an estimated $30.5K and bringing the position to 3,262 shares worth $311K. The position accounts for 0.03% of the portfolio, ranked #158.

Doyle Wealth Management first reported a position in CVS in Q1 2017 and has held it in 22 quarters since. The position peaked at $340K in Q4 2021. 2,325 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • Doyle Wealth Management held 3,262 shares of CVS Health worth $311K as of Q3 2022.
  • Doyle Wealth Management bought 308 CVS Health shares in Q3 2022, an estimated $30.5K.
  • CVS Health made up 0.03% of Doyle Wealth Management's portfolio in Q3 2022, its #158 holding.
  • Doyle Wealth Management first reported a position in CVS Health in Q1 2017 and has held it in 22 quarters since.
  • Doyle Wealth Management's CVS Health position peaked at $340K in Q4 2021.
  • 2,325 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on Doyle Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.